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As MIR prepares for its 60th anniversary reunion in 1991, the 1966-1967 residents and fellows 
will join in the celebration for their 25th anniversary. Seated, left to right, are Doctors William 
Miller; Richard Irackler; Juan Taveras, director of the Institute from 1964 to 1971; Hugh M. 
Wilson, director of the Institute from 1949 to 1963; William Mill; and Robert Hurley. Middle 
row, left to right, are Doctors C. Jay Kees; Katherine Jacobs; John Bardsley, presently on staff 
as assistant professor of clinical radiology; Gerald Shaikun, presently on staff as instructor 
in clinical radiology; Charles Williams; and Allan McCown, presently on staff as assistant 
professor of clinical radiology. Back row, left to right, are Doctors Myo Kyaw, John Fenlon, 
James Debnam, andEmilio Torres-Reyes. Photograph courtesy of the Office of the Director— 
Mallinckrodt Institute of Radiology. 
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6     AND BABY MAKES THREE 
An interventional radiology procedure called selective ostial salpingography and 
recanalization is making dreams come true for some of the 3.5 million infertile 







12    BREATHING EASY 
Surgeons and radiologists are collaborating in a study that promises to detect 
early rejection of lung transplants in emphysema patients. 
18    JOINT EFFORT 
Magnetic resonance imaging has become the procedure of choice for diagnosing 
sports injuries to the joints. 
SPOT NEWS 
23      FYI 
31      REFLECTIONS 
ON THE COVER: , 
On March 21, 1988, Connie Pisetta became the first patient at MIR to undergo selective 
ostial salpingography. Brenden is the happy result. 
Photograph by Cliff Willis. 







The Society of Nuclear 
Medicine (SNM) annually 
presents the prestigious 
Aebersold Award to that 
researcher whose work has 
produced outstanding 
achievements in the field 
of nuclear medicine while 
promoting a widespread 
appreciation of the scien- 
tific value of nuclear medi- 
cine through basic and 
clinical research. Marcus 
Raichle, M.D., professor of 
radiology and neurology, was 
the logical and deserving 
choice for this year's honor, 
which was presented at the 
Society's 36th Annual 
Meeting held in June. 
For the past two decades, 
Raichle has focused his 
attention and efforts on 
the study of the human 
brain. Using the tools of 
nuclear medicine, espe- 
cially cyclotron-produced 
short-lived radionuclides 
and positron emission 
tomography (PET), Raichle's 
studies of cerebral blood 
flow and metabolism have 
provided a sound scientific 
foundation on which other 
researchers can build. 
Raichle began using 
positron-emitting cyclotron- 
produced radionuclides 
coupled with angiography 
for studies of human and 
other primate brains as far 
back as 1971, at a time 
when other neurosciences 
researchers were not familiar 
with the tracers. His desire 
to find a less invasive 
method of studying the 
brain led Raichle to PET 
and the development of 
methods for the measure- 
ment of regional cerebral 
blood flow and metabolism; 
methods that to this day 
are regarded as the only 
Marcus Raichle, M.D., is a 
pioneer in the field of 
cerebral blood flow and 
metabolism. 
procedure to use. 
Within the past 10 
years, Raichle's work has 
focused on the application 
of PET to the study of psy- 
chiatric disorders and 
developing functional maps 
of the areas of the brain 







Robert R. Kuske, M.D., 
assistant professor of radi- 
ology and chief of breast 
service in Radiation Oncol- 
ogy, had some good news to 
share at the Second Inter- 
national Brachytherapy 
and Remote Afterloading 
Symposium held April 
19-21 in St. Louis. 
In his study involving 
417 women with breast 
cancer who were followed 
a minimum of five years after 
treatment and half of whom 
received radiation breast 
implants (brachytherapy), 
Kuske reported a low 4.6 
percent recurrence of 
breast cancer—one of the 
lowest figures reported in 
medical literature. 
According to statistics 
from the American Cancer 
Society (ACS), more than 
1,000 women in Missouri will 
die from breast cancer in 
1990. The Department of 
Health also had a startling 
prediction for Missouri— 
3,200 new cases of breast 
cancer will be diagnosed 
this year. With the increas- 
ing incidence of breast 
cancer and the public's 
increased awareness of the 
disease, more women now 
are aware of the various 
treatment options. Many 
patients are choosing lump- 
ectomy (removing only the 
malignant lump plus a mar- 
gin of surrounding tissue) 
followed by radiation. 
Some of these women will 
have radiation implants 
placed in the affected 
breast in addition to stan- 
dard external radiotherapy. 
It is this group of women in 
whom the recurrence rates 
have been lowered so 
drastically. 
According to Kuske, 
"Brachytherapy shortens 
the overall treatment time 
because the implant gives 
two weeks worth of radia- 
tion in two days. This treat- 
ment option gives a higher 
dose of radiation and it's 
concentrated on the area 
of the breast at highest 
risk. We can also target 
large tumors that are 
located deep in the breast 
tissue." 
MALLINCKRODT INSTITUTE OF RADIOLOGY 






Bruce L. McClennan, 
M.D., professor of radiology, 
has been appointed a con- 
sultant to the Center for 
Drug Evaluation and 
Research by the Food and 
Drug Administration (FDA). 
The Center reviews and 
approves all U.S. prescrip- 
tion drugs and monitors the 
quality of marketed drug 
products as well as con- 
ducts research and develops 
scientific standards on the 
quality, safety and effec- 
tiveness of drugs for 
human use. 
McClennan, a nationally 
recognized expert in the 
field of genitourinary radi- 
ological research and in the 
assessment of radioiodinated 
contrast agents, will advise 
the Center on the safety 
and efficacy of substances 
proposed for use in the 
treatment or diagnosis of 
diseases and illnesses. 
Winthrop 
Award Goes to 
Mirowitz 
A team of researchers 
led by Scott A. Mirowitz, 
M.D., instructor of radiol- 
ogy, has developed a tech- 
nique for magnetic 
resonance imaging of the 
upper abdominal area. The 
results of their research 
was published in the April, 
1990 issue of the journal, 
Radiology, and was placed 
into competition at the 
annual meeting of the 
Society of Computed Body 
Tomography held recently 
in Palm Springs, California. 
From more than 20 
papers presented for the 
competition, Mirowitz, along 
with Joseph K. T. Lee, 
M.D.; Jeffrey J. Brown, 
M.D.; Steven S. Eilenberg, 
M.D.; Jay P. Heiken, M.D.; 
and William Perman, Ph.D., 
received one of three major 
awards—the prestigious 
Winthrop Award, which 
carries a $10,000 grant for 
further research. 
Called rapid acquisition 
spin-echo (RASE), the tech- 
nique produces images that 
are free of respiratory- 
induced blurring while 
allowing for dynamic con- 
trast material-enhanced 
scanning of the entire liver 
using the contrast agent, 
gadolinium. The study, the 
only one of its kind in the 
United States, involved the 
imaging of various organs 
in 100 patients who each 
had to hold his breath for 
23 seconds, which is well 
within the breath-holding 
capability of most patients, 
while a contrast agent was 
administered intravenously. 
According to Mirowitz, 
'Although previous studies 
have demonstrated superior 
sensitivity of magnetic 
resonance imaging compared 
to computed tomography in 
detecting liver lesions, 
implementation of MR for 
scanning the upper abdomen 
has been met with several 
obstacles. Foremost among 
these obstacles are the long 
acquisition times and the 
degrading effects of physio- 
logic motion, such as 
breathing, on the MR image." 
This breath-holding tech- 
nique will improve the 
quality of MR images as 
well as reduce imaging 
times for claustrophobic 
patients or those with 
other conditions that limit 
tolerance of extended 
imaging times. 
Ronald G. Evens, M.D., 
director of the Institute, 
greeted the members of 
Greater Missouri: Focus on 
Leadership. This diverse 
group of professional women 
believes that effective leader- 
ship calls for knowledge as 
well as commitment. Evens 
talked about the health-care 
dilemma our society faces: 
how to make a shrinking 
budget cover costlier health 
care. "The answer ulti- 
mately lies with you; you 
will have to decide what you 
are willing to forgo in the 
way of medical technology. 
We can't have it all," 
explained Evens to more 




Joseph L. Roti Roti, 
Ph.D., professor of radiol- 
ogy and chief of the cancer 
biology section, has been 
elected to a three-year 
term for the office of 
councilor-at-large of the 
Radiation Research Society 
in recognition of his contri- 
butions to cancer biology 
research, his work in the 
measurement of molecular 
changes in cancer cells' 
response to heat and radia- 
tion, and his development 
of mathematical tools 
measuring the effects of 
radiation and heat. Roti Roti's 
research has centered on 
the mechanisms of cell 
response to radiation, 
chemotherapy, and hyper- 
thermia with emphasis on 
cell kinetics and nuclear 
targets. 
As one of 10 members 
serving in this capacity, 
Roti Roti will assist in 
policy recommendations and 
changes and committee 
reports as well as voting on 
issues and bylaws. 
An international 
organization of over 2,000 
scientists, the 38-year-old 
Radiation Research Society 
encourages the advance- 
ment of radiation research 
in all areas of the natural 
sciences while promoting 
the dissemination of 
knowledge. 






William J. Hoskins, M.D., 
guest speaker for the annual 
Probstein Oncology Lecture, 
had some disturbing sta- 
tistics to share with his 
audience: more than 20,000 
women in the United States 
will be diagnosed with 
ovarian cancer (attributed 
to 29 percent of cancers in 
women), and 53 percent of 
those women will die as a 
result of the disease. 
The cause of ovarian 
cancer is unknown; there is 
no screening examination 
as there is the Pap smear 
for cervical cancer or the 
mammogram for breast 
cancer. Called "the silent 
killer," ovarian cancer 
usually demonstrates no 
signs or symptoms until the 
disease is in an advanced 
stage. This cancer tends to 
spread quickly throughout 
the abdominal area, often 
involving lymph glands, the 
liver, or the lungs. 
Hoskins, associate chief 
of the gynecology service 
at Memorial Sloan-Kettering 
Cancer Center and associate 
professor of obstetrics/ 
gynecology at Cornell Uni- 
versity Medical Center in 
New York, pointed out in 
his talk, "Ovarian Cancer: 
Current Treatment and 
Future Perspective," that 
there is a bright spot in the 
fight against this disease. 
The National Cancer Insti- 
tute has formed a task 
force to establish some 
(left to right) William J. 
Hoskins, M.D., speaker for 
the 1990 Probstein Oncology 
Lecture and an advocate for 
the development of a screening 
method for ovarian cancer, 
was cited for his contributions 
to clinical oncology by Carlos 
A. Perez, M.D., director of 
the Radiation Oncology 
Center. 
method of screening for 
ovarian cancer. Research 
into the staging of this 
cancer holds great promise. 
In one of Hoskins' 
studies involving 67 
patients, 25 percent of 
those women whose cancer 
had been detected and 
then had undergone sur- 
gery had tumors remaining 
after surgery. 
"The importance of 
surgical evaluation of the 
entire tumor area and its 
staging is critical in the 
second look. The less 
tumor remaining at the end 
of surgery, the better the 
survival rate," said 
Hoskins. 
According to Hoskins, 
chemotherapy will play a 
major role in defeating 
ovarian cancer. Patients 
will have a 50 percent 
chance of survival if 
tumors remaining after sur- 
gery are detected and if 
surgery is followed by 
chemotherapy. 
"A very intensive 
chemotherapy treatment 
plan, a high dose adminis- 
tered intravenously, may be 






In the 23 years since 
Michael J. Welch, Ph.D., 
professor of radiation 
chemistry, first joined the 
MIR staff, his contributions 
in the field of radiophar- 
maceutical chemistry have 
been many. His work, 
focusing on the labeling of 
chemical compounds with 
short-lived radionuclides, is 
cited worldwide, and the 
compounds developed by 
Welch and his research 
team are used for medical 
research and diagnosis 
throughout the world. 
In recognition of his 
achievements, the more 
than 30,000 members of 
the American Chemical 
Society (ACS) selected 
Welch as recipient of the 
prestigious ACS Award for 
Nuclear Chemistry. The 
presentation was made in 
April at the 199th ACS 
National Meeting in Boston. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 





Henry D. Royal, M.D., 
associate professor of radi- 
ology and associate director 
of Nuclear Medicine, was 
one of two U.S. physicians 
invited to participate in an 
in-depth study of illnesses 
attributed to the 1986 
nuclear reactor explosion 
in Chernobyl. Prompted by 
a request from the Inter- 
national Atomic Energy 
Agency (IAEA) and the 
Soviet government, Royal, 
who serves on the IAEA's 
medical effects team, 
reviewed data collected by 
Soviet scientists regarding 
the effects of the nuclear 
accident. 
The IAEA includes 
representatives from 113 
countries who are considered 
experts in the fields of 
radiation protection, medi- 
cine, epidemiology, radio- 
ecology and psychology. 
The medical effects team 
analyzed the clinical health 
effects from radiation 
exposure and evaluated the 
general health situation in 
the areas of corroboration 
of bioassay and biological 
dosimetry, blood disorders, 
immune function, lead tox- 
icity, neoplasms, thyroid 
disease, the effects on 
pregnancy and birth rate, 
nutrition analysis, cataracts, 
and stress effects. 
The government and 
the people of the Soviet 
Union are concerned about 
the radiological conse- 
quences from the nuclear 
accident as well as the 
impact of living in contami- 
nated areas. "The people 
are our main concern," said 
Royal. "Although a com- 
plete assessment of the 
effects of the accident will 
take many years, the pres- 
ence of an independent 
team of international experts 
hopefully will alleviate 
some of the anxiety of the 
Soviet people." 
The medical effects 
team will make a second 
visit in the fall of 1990 to 
perform its own health sur- 
vey, examining the people 
from contaminated and 
noncontaminated villages 
to determine the incidence 





For the fourth consecu- 
tive year, the presentation 
of the Hugh M. Wilson 
Award was made to two 
graduating medical stu- 
dents who made meritori- 
ous contributions to the 
Department of Radiology. 
The 1990 recipients are 
Paul L. Chesis, M.D., Ph.D., 
and Christopher M. 
Speidel, M.D. 
According to Fernando 
R. Gutierrez, M.D., associ- 
ate professor of radiology, 
who assisted in reviewing 
the nominations, "Each 
year the continuous high 
quality of the nominees 
causes the selection 
process to become more 
and more difficult. This 
year's nominees have made 
significant contributions 
with their work at the 
Institute.'' 
Chesis, who completed 
his Ph.D. studies while 
working with Michael J. 
According to Ernest L. 
Wynder, M.D., president and 
founder of the American 
Health Foundation and key- 
note speaker for the 1990 
Freund Lecture, "Thefunc- 
tion of medicine is to help 
people die young as late in 
life as possible." Wynder's 
lecture, "Cancer Prevention 
and the Role of Nutrition," 
highlighted the correlation 
between lung cancer and 
smoking and dietary fat. 
Carlos A. Perez, M.D., (right) 
honored Wynder for his 
meritorious research in 
clinical oncology. 
Welch, Ph.D., professor of 
radiation chemistry, con- 
ducted research on the 
synthesis and characteriza- 
tion of positron emitting 
ligands for the opioid 
receptor system. His work 
has resulted in four publi- 
cations (one in the Journal 
of Nuclear Medicine and 
three in press) as well as five 
presentations at the Society 
of Nuclear Medicine meet- 
ing in June. 
In his work with 
Michael W. Vannier, M.D., 
professor of radiology and 
director of the image 
processing lab, Speidel 
implemented a comprehen- 
sive computerized database 
consisting of thousands of 
examination records. 
"Speidel's research in the 
area of multispectral mag- 
netic resonance image 
analysis is very important 
in our laboratory," said 
Vannier. 
Chesis and Speidel were 
officially presented with the 
Wilson Award, which 
honors former Mallinckrodt 
Institute Director Hugh M. 
Wilson, by Ronald G. 
Evens, M.D., director of the 
Institute, at the Annual 
Senior Awards night in May. 
FOCAL SPOT, SUMMER, 1990 
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o matter what 
room you are in, the cozy home of 
Jim and Connie Pisetta in suburban 
St. Louis conveys a distinct mes- 
sage: A baby lives here. Playpen in 
the living room. Pediatrician's 
phone number on a kitchen black- 
board. Baby pictures on the 
refrigerator door. Stenciled teddy 
bears in a small bedroom belonging 
to eight-month-old Brenden. 
But as the plump child sleeps in 
his mother's arms, Connie Pisetta 
recalls a time when this scene was 
only a dream. Before Brenden was 
conceived, she and Jim had waged 
a war against their infertility—in 
their case, caused by an obstruction 
in Connie's Fallopian tubes. Riding 
an emotional roller coaster of hope 
and despair, Connie eventually 
stopped going to the baby showers 
of friends and relatives. 
"I was happy they could have 
a baby," says Connie, 33, "but it just 
reminded me of something I really 
wanted and couldn't have." 
By Robert Lowes 
H^OT^MinTOMMW^IIMHiim^ \mmmvMtwSm 
hanks to an innovative, two- 
step procedure for infertile 
women, available through 
the Mallinckrodt Institute of 
Radiology (MIR) and Barnes 
Hospital at the Washington 
University Medical Center, Connie 
and Jim Pisetta's dream has 
come true. The new technique, 
which pinpoints and removes 
blockage in the Fallopian tubes 
without surgery, is beginning to 
produce results for some of the 
nation's 3.5 million infertile 
couples. 
McClennan calls the success 
rate of 58 percent a "statistical 
variant" and predicts that as he 
performs more of the procedures, 
the success rate will resemble 
the somewhat lower percentages 
attained by Amy S. Thurmond, 
M.D., the radiologist at the 
Oregon Health Sciences Univer- 
Clogged or diseased 
Fallopian tubes 
account for between 
30 and 50 percent of 
all cases of female 
infertility. 
sity in Portland who perfected 
the technique. 
"Depending upon the back- 
ground of the women and the 
length of follow-up, we're seeing 
success rates between thirty and 
fifty percent," says Thurmond, 
an assistant professor of radiol- 
ogy and obstetrics-gynecology. 
Bruce L. McClennan, M.D. 
ne reason for the 
higher success rate in 
I St. Louis could be the 
careful follow-up," explains 
Pineda. "Identification and treat- 
ment of other factors contributing 
to the infertility in many of our 
patients explain—in my belief— 
our success. This case is just one 
of many examples we have with 
more than one factor present." 
McClennan notes that the 
selective ostial salpingography 
and recanalization performed at 
both Washington University Med- 
ical Center and Oregon Health 
Sciences University has involved 
the so-called proximal (initial) 
section of the Fallopian tube 
feeding into the uterus. Blockage 
here usually stems from easily 
removed webs or debris. Recanali- 
zation is not effective in the 
peripheral portions of the tubes 
near the ovaries, where scar 
tissue following an infection is a 
common cause for blockage. Scar 
tissue often does not give way to 
a probing catheter or guide wire. 
The proximal section also invites 
the new procedure because it is 
smaller in diameter than the 
peripheral section, close to the 
uterus itself, and thus less acces- 
sible to surgeons. 
Selective ostial salpingography 
and recanalization, introduced in 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
1986, boasts several advantages 
over traditional methods to treat 
blocked Fallopian tubes. Hystero- 
salpingography (HSG) has been 
the standard test for detecting 
occlusions. A contrast medium is 
injected into the uterus as 
opposed to the Fallopian tubes 
themselves. HSG uncovers tubal 
barriers, but does not define 
them as precisely as selective 
ostial salpingography. The latter 
technique, for example, can tell 
whether blockage is due to a 
muscle spasm or an actual 
physical barrier. 
Clogged or diseased Fallopian 
tubes account for between 30 
and 50 percent of all cases of 
female infertility, which in turn 
is responsible for 60 percent of 
all infertile couples. Dysfunc- 
tional tubes prevent the union of 
sperm and egg necessary for 
conception. 
Selective ostial salpingography, 
the first step of the procedure 
used with Connie, involves 
injecting a contrast medium into 
the openings, or ostia, of the 
Fallopian tubes via a catheter. 
An X ray will reveal any barrier, 
such as a plug of mucus or scar 
tissue. In the procedure's second 
step, called recanalization, a 
flexible, soft-tipped wire is 
pushed through the catheter into 
the Fallopian tubes to penetrate 
and/or bypass the obstructions. 
A radiologist frequently can 
open a tube by manipulating the 
catheter without resorting to the 
wire. In some cases, recanaliza- 
tion per se is not necessary; the 
contrast medium itself will clear 
out the tubes. Because the tubes 
can shut down again over time, a 
few women must have a second 
recanalization. 
■ I n March 21, 1988, Connie 
^JJlPisetta became the first 
1 patient to undergo selec- 
tive ostial salpingography and 
recanalization at the Washington 
University Medical Center. Doing 
the honors were Bruce L. 
McClennan, M.D., professor of 
radiology at MIR, and Jorge 
Pineda, M.D., assistant professor 
in the Obstetrics-Gynecology 
Department of Washington 




crashed. Jim kept 
his eocpectations in 
check as a 
counterbalance. 
Division of Reproductive 
Endocrinology. 
Since then, McClennan, 
Pineda and other members of 
the Obstetrics-Gynecology 
Department have performed the 
procedure on over 30 patients. 
Among the first 25 patients 
selected for follow-up study, 22 
had at least one Fallopian tube 
opened and 17 of these were 
attempting to conceive after 
recanalization. Ten of these 17 
patients indeed became pregnant, 
a success rate of 58 percent. 
While two women had three mis- 
carriages and another an ectopic 
pregnancy, five other women 
delivered babies—four boys and 
one girl—and two had ongoing 
pregnancies as of June, 1990. 
ntil recanalization came 
along, infertility 
specialists routinely 
turned to surgery to unblock 
Fallopian tubes. The defective 
portion is excised and the ends 
refastened. However, the patient 
typically spends several hours on 
the operating table and four days 
in the hospital. Her medical bills 
run as high as $10,000. The 
recovery period can stretch out 
for four weeks. Plus, the patient 
might not know for months 
whether her tubes are functional. 
In contrast, selective ostial 
salpingography and recanaliza- 
tion can be performed together 
on an out-patient basis in less 
than 45 minutes using little or no 
intravenous sedation. A second 
injection of contrast medium 
This soft-tipped flexible guide wire 
(placed on top of the hysterosalpingo- 
gram here) is fed inside a catheter 
through the cervix, across the uterus, 
and into the Fallopian tube. 
DI0LOCY  UHSHIHCTOH   UHIV 
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immediately following recanali- 
zation confirms whether the 
tubes are open, sparing the 
patient months of uncertainty. 
She also avoids the risks asso- 
ciated with surgery. Recovery is 
a matter of hours, not weeks. 
And the cost is about $1,000—an 
important consideration for 
infertile couples who normally 
spend a great deal of money 
attempting to conceive. 
The new procedure also out- 
shines the old in terms of effi- 
cacy. ' 'The overall viable preg- 
nancy rate we quote for surgery 
will be between twenty to forty 
percent," says Pineda. And in 
vitro fertilization, another 
expensive option, yields pregnan- 
cies only 15 percent of the time. 
For Connie Pisetta, however, 
the only statistic worth knowing 
about infertility cures is one 
called Brenden Pisetta. 
"The happiest day of my life, 
I would have to say, was when 
this little guy was born and I 
heard him cry," says Pisetta, a 
hairstylist with seven brothers 
and sisters. 
any unhappy days had 
gone before. Connie and 
her husband Jim, 35, a 
county construction inspector, 
had been married a year when, 
in 1986, they decided to start 
their family. Connie had vowed 
to have a baby by the age of 30. 
Yet after six months of unpro- 
tected intercourse (the time it 
usually takes for one of every 
two women to become pregnant 
the first time), the Pisettas' 
family remained at two. 
They sought help from 
Connie's doctor. Jim underwent 
sperm tests. Connie was tested 
to determine whether she was 
ovulating properly, and, yes, she 
was. Another test, however, 
showed that her progesterone 
output was low, so her physician 
prescribed drug therapy to raise 
the level. Connie took her basal 
"There are few things 
I've done in radiology 
as gratifying as 
helping someone have 
a live birth." 
Bruce McClennan, M.D. 
body temperature religiously to 
identify the most fertile days of 
her menstrual cycle. She and her 
husband prayed. Still no baby. 
Her 30th birthday was coming 
up fast. Connie says her goal of 
motherhood became an obsession. 
"All my sisters had babies 
and I'm the oldest, and I still 
didn't have a baby,'' says Connie. 
"I became very, very moody. It 
seemed like every month, I 
would live two weeks at a time. 
I'd think, 'Two weeks from now I 
will ovulate and two weeks from 
then I'll probably be pregnant.' 
When I had my period, I would 
actually mourn. It was just a 
letdown, such a big, bitter 
letdown." 
Connie's hopes repeatedly 
skyrocketed and crashed. Jim 
kept his expectations in check as 
a counterbalance. 
"I tried never to get too emo- 
tionally high," he says. "She 
sometimes thought I wasn't con- 
cerned enough." 
With its load of anguish and 
guilt, infertility crushes many a 
marriage. It tested the strength 
of Connie's and Jim's marriage, 
but despite scheduled sex, endless 
tests and false-alarm pregnancies, 
their foundation of love didn't 
crack. 
"I told her if we don't have 
children, I'll still love her and 
grow old with her," says Jim. 
onnie's private physician 
finally referred her to 
Pineda at the Washington 
University Medical Center in late 
1987 after an HSG suggested her 
Fallopian tubes were blocked. A 
laparoscopy, in which an endo- 
scope is inserted through an inci- 
sion through the navel, failed to 
reveal any kinking or scarring 
that might have shut down her 
tubes. These findings, says 
Pineda, suggested that debris in 
the proximal section of the tubes 
was the culprit. 
Connie was scheduled for 
selective ostial salpingography 
and recanalization at 7:30 a.m., 
March 21, 1988. Because this was 
Mallinckrodt Institute's first, "we 
did the procedure in the operating 
room," says McClennan. "We took 
every precaution known to man." 
Under fluoroscopic guidance, 
a catheter was advanced through 
the cervix, across the uterus and 
to the opening of one Fallopian 
tube. McClennan injected the 
contrast medium. Where the 
contrast medium stopped flow- 
ing in the tube marked the 
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occlusion. Then McClennan 
inserted a smaller catheter 
inside the first catheter. Inside 
the second catheter went a 
guide wire. Two pairs of hands 
were needed to snake the small 
catheter and wire into the Fallo- 
pian tube. Recanalization took 
only a few minutes. Pineda recalls 
that the barrier felt very soft. 
McClennan flushed contrast 
medium into the tube again. This 
time, it filled up completely- 
proof that the obstruction was 
gone. The process was repeated 
for the second tube. It, too, 
was opened. 
Connie's joy over the success- 
ful procedure outweighed the 
slight discomfort she was experi- 
encing. She eagerly asked Pineda 
if she and Jim could resume their 
baby-making efforts. Pineda 
advised her to wait a month for 
safety's sake. 
Pregnancy eluded the 
Pisettas for many months, and 
Pineda urged his anxious patient 
to relax. "He could see this was 
taking over my life," she says. 
Fortunately, Pineda spotted the 
last problem. Because Connie 
didn't produce enough progester- 
one on her own, her uterine 
lining did not mature to the 
point where it could support a 
fertilized, implanted egg. There- 
fore, Pineda prescribed Clomid 
as well as another hormonal 
medication to boost her 
progesterone production. 
inally, in March 1989, a 
I pregnancy test proved posi- 
1 tive. Connie recalls coming 
home to tell Jim, "We're going to 
have a baby! We're really going 
to have a baby!" After tears of 
joy, the Pisettas celebrated by 
dining on linguine in shrimp 
sauce at an Italian restaurant. 
These days, Connie cooks 
supper with one arm while 
cradling Brenden in the other. 
Jim makes late-night runs for 
baby food and formula. Although 
some of the initial awe of Brenden's 
birth has worn off, the Pisettas 
like parenthood enough to want 
a second child someday. That 
goal is no painfully entertained 
fantasy, now that radiologists 
and gynecologists can journey 
into Fallopian tubes to open 
what nature has closed. 
"There are few things I've 
done in radiology as gratifying as 
helping someone have a live 
birth," says McClennan. □ 
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Varline and Marvin Russell are 
headed home after Marvin's six-month 
checkup got a thumbs-up result. 
ost of us take breathing for 
I \I I Sranted- We don't have to 
think about it or push a 
button to make it happen—we just 
breathe, effortlessly and automatically. 
But for some breathing becomes an all- 
consuming task. 
Ask emphysema sufferers what part of 
their lives are concerned with the problem of 
breathing, and most will say 100 percent. There are 
more than 1.9 million people in the United States 
who have varying stages of emphysema, which is 
categorized as a chronic obstructive pulmonary dis- 
ease (COPD) along with asthma and chronic bron- 
chitis. Patients with an advanced form of the 
disease literally can smother to death from the large 
pools of air held in their lungs. The outlook, 
however, is not as bleak as it appears. There is hope 
for emphysema patients. 
BREATHING EASY 
Joel D. Cooper, M.D., professor 
of surgery and head of the 
Section of Thoracic Surgery 
at Barnes Hospital, and Dixie J. 
Anderson, M.D., associate pro- 
fessor of radiology at the Mallin- 
ckrodt Institute of Radiology, are 
collaborating on a study involving 
patients who have undergone sin- 
gle lung transplants for 
emphysema. The two most com- 
mon complications for transplant 
cases are infection and rejection. 
Anderson and Cooper hope this 
study, the first of its kind involving 
this particular type of surgery, 
will play a key role in the detec- 
tion of either of these two 
problems. 
Marvin Russell of Fordyce, 
Arkansas, has emphysema. A 
robust man of 56, Russell says 
now he is having the time of his 
life, thanks to a lung transplant 
performed by Cooper and his 
thoracic surgery team in November 
of 1989. Russell was diagnosed as 
having emphysema by his physi- 
cian in Arkansas during a routine 
physical examination eight years 
ago. According to Russell, the 
diagnosis was a complete sur- 
prise. He appeared to have none 
of the symptoms commonly 
indicating emphysema: a barrel- 
shaped chest caused by an over- 
abundance of air in the lungs, 
severe breathlessness from any 
type of exertion, weight loss, fre- 
quent swelling in the arms and 
legs, a bluish tinge to the skin 
caused by insufficient gas 
exchange, tightness in the chest 
area, wheezing, or intolerance to 
cold or smokey atmospheres. 
Dixie Anderson, M.D. 
The exam showed that Russell's 
lung capacity was below the 
accepted average level. The cul- 
prit? In Russell's case, it was 
undoubtedly his habit of smoking 
two packs of cigarettes a day, a 
habit he had cultivated since the 
age of 26. According to Cooper, 
"Emphysema falls into two 
categories: smoking-induced or 
inherited, with smoking-induced 
being the more common of the 
two, especially in older patients. 
Emphysema in younger patients 
usually stems from an inherited 
predisposition to the disease." 
What is this disease called 
emphysema? To under- 
stand the disease, we 
need to understand exactly what 
part the lungs play in the make- 
up of our bodies. The right lung 
has three lobes (or portions): 
superior, middle, and inferior. 
The left lung has two: superior 
and inferior. Each lung is sur- 
rounded by two layers of protec- 
tive tissue called pleura. The 
lungs are made up of air passage- 
ways (bronchi), gas exchange 
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sacs (alveoli), and numerous blood 
vessels. Situated under the rib 
cage and protected and supported 
by 12 pairs of ribs, muscles, and 
the diaphragm, the lungs provide 
our bodies with oxygen—without 
oxygen, no organ or tissue can 
survive. 
Oxygen, paired with chemical 
reactions in our bodies, produces 
energy. Carbon dioxide, a waste 
The two most 
common 
complications for 
transplant cases are 
infection and 
rejection. 
product of these reactions, must 
be removed from the body, and 
this exchange of inhaled oxygen 
and exhaled carbon dioxide is 
why our lungs are so important. 
In end-stage emphysema, 
both lungs are affected as they 
no longer perform their vital gas 
exchange functions. Large pools 
of air fill the lungs, causing the 
air ducts and air sacs to distend 
either throughout the lungs or in 
particular sections. This enlarge- 
ment often causes destruction of 
the partitions between the air 
sacs. The lung tissue loses elastic- 
ity and, therefore, cannot push 
out the air. The capillary walls 
are diminished or disappear en- 
tirely. The lung tissue becomes 
dry and pale from malnutrition 
and has a "lacy" appearance. 
Russell's wife, Earline, says, 
"Marvin isn't the type to 
just lie down and give in to 
being ill. At first, he kept right 
on working in the garden and 
fishing and doing almost every- 
thing he had always done." 
However, Russell's condition 
rapidly deteriorated and within 
the six years following his initial 
diagnosis, his life drastically 
changed. As breathing became 
more and more difficult, Russell 
had to forgo many of the activ- 
ities he had always enjoyed. 
Eventually the disease forced 
him into an early retirement 
from his position as director of 
the Assessment Coordination 
Division of the Public Service 
Commission for the State of 
Arkansas. He acquired a new 
companion—a tank of portable 
oxygen. And, finally, he was 
dealt the final blow; his doctors 
told him he had from eight to 12 
months to live. 
"I guess that was the lowest 
point in my life," says Russell. "I 
considered myself a fairly young 
man, too young to die. Earline 
and I have nine children and 
twenty-three grandchildren. I 
had a lot of reasons to live." 
Russell credits oldest son 
Steve with saving his life, "along 
with Doctor Cooper," he quickly 
adds. Steve was in the home-care 
field of inhalation therapy and 
had heard about a surgeon in 
Toronto, who, in 1986, had 
begun working with double-lung 
transplantations in emphysema 
patients. That surgeon was Joel 
Cooper. A call was made to 
Toronto in an effort to learn 
more about the procedure. 
Russell explains, ' At first 
thought, the drawbacks seemed 
overwhelming—all the costs of 
traveling to Canada for the 
transplant plus the transplant 
itself and the fact that the odds 
of surviving the tranplant were 
about one percent. But I decided 
that somehow everything would 
work out, and I didn't care what 
the odds were. Any odds were 
better than what I had." 
A sprinkling of luck and a 
large dose of the Russell family's 
strong faith seemed to intervene. 
Cooper transferred from Toronto 
to the Washington University 
Medical Center in St. Louis, or, 
as Russell says, ' 'practically in 
my backyard." 
The Russells headed to St. 
Louis. After a two-week 
evaluation of his condition 
by a transplant team (which 
included a pulmonary physician, 
a thoracic surgeon, a cardiolo- 
gist, a cardiovascular surgeon, 
the transplant coordinator, a 
psychologist, a dietician, a social 
worker, and a pulmonary ther- 
apist), Russell was accepted as a 
candidate for lung transplanta- 
tion. Based on the results of 
several tests, the evaluation 
team determined that Russell's 
right lung had the lowest 
exchange of air and, therefore, 
was the lung to be replaced. 
Now came the hard part, waiting 
for a suitable donor. 
In lung transplants, and all 
transplant procedures, time is 
crucial. A lung must be trans- 
planted within six hours from 
the time of removal from the 
donor. Out of necessity, the 
Russells remained in St. Louis, 
renting an apartment near the 
Medical Center. Russell was told 
that a donor lung could be avail- 
able anywhere from two days up 
to six months. His subsequent 
days were filled with hope as 
well as fear and frustration. 
But as Russell explains, "The 
fear was minimal. All I could 
think about was that I was being 
given a second chance." 
FOCAL SPOT, SUMMER, 1990 15 
BREATHING EASY 
By November of 1989, 
within two months of his 
acceptance into the pro- 
gram, Russell was in the operating 
room receiving a new right lung 
from a donor who matched Russell 
in height, weight, chest meas- 
urements, and blood type. 
During the six weeks following 
Russell's transplant, he under- 
went dozens of tests and his X 
rays became part of a study con- 
ducted by Anderson aimed at 
the detection of complications. A 
definite plus in transplant proce- 
dures is the early detection of 
any complications that could 
lead to infection or rejection. 
Early detection can mean the 
difference between successful 
treatment or losing the trans- 
planted organ or possibly the 
patient. 
Cooper, the pioneer in the 
field of lung transplantation in 
emphysema patients, performed 
the first successful transplant in 
North America in 1986 while in 
Toronto. In the early stages of 
the program, Cooper said that 
the double-lung transplant was 
very complicated and not well 
tolerated by older patients. 
Eventually, the program placed 
an age restriction on candidates: 
only those patients 50 years old 
or younger would be eligible. 
What about these so-called 
high-risk patients over 50? 
Cooper knew that one or two 
successful single transplants had 
been done in Paris. He was 
determined to redesign his pro- 
gram to accommodate the age 
group where emphysema 
appeared to be more prevalent. 
The lung transplant program 
at the Washington Univer- 
sity Medical Center began 
in July, 1988, and has involved 
more than 40 patients, with 20 
of these patients suffering with 
emphysema. The Medical Center 
boasts the largest transplant pro- 
gram in North America, with 
similar programs available only 
in San Antonio and Toronto. 
Anderson's and Cooper's study 
focuses on 11 of these emphysema 
patients who had undergone 
single-lung transplants since 
May, 1989. 
According to Anderson, "A 
series of chest radiographs were 
reviewed to determine the usual 
postoperative appearance of the 
transplant and to evaluate 
changes correlating with specific 
complications. We organized 
these films according to the 
number of the week following 
surgery, first week out, second, 
and so on." 
Anderson's eyes searched the 
films for volume loss, the 
presence of liquid in the pleura 
of the thoracic and lung cavity, 
In 1986, Joel D. Cooper, M.D., per- 
formed the first successful lung trans- 
plant in an emphysema patient in 
North America. 
and variations in the positioning 
of the diaphragm, or collections 
of air in the lung. For study pur- 
poses, the lung was divided into 
four regions: perihilar (that area 
of the lung where the bronchial 
tubes, blood vessels, and nerves 
enter the lung), apical (the 
rounded upper portion of the 
lung), midlung, and lower lung. 
Each of the four areas was 
evaluated for the fluids, cells, or 
other abnormalities that had 
accumulated in the lung tissue. 
Ventilation perfusion studies 
measuring the exchange of air 
between the lungs and the sur- 
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rounding air were obtained on 
the first postoperative day and 
at regularly scheduled intervals 
thereafter. These results then 
were compared with the studies 
taken before the operation. 
Computed tomography (CT) 
scans evaluated any abnormal 
opacity on the chest X rays or a 
suspected tear in the airway. In 
addition, fluoroscopy was admin- 
istered to show diaphragmatic 
motion, an angiogram assessed 
vascular conditions, and a bron- 
chogram monitored the incision 
made in the bronchial tube in 
order to attach the new lung. 
Test results from each of the 
11 patients were individually and 
collectively recorded, analyzed, 
and compared. As a result, 
Anderson believes that (1) the 
chest X ray will very likely show 
changes in the transplanted lung 
within the first six weeks following 
surgery, especially in the perihilar 
and lower lung region, (2) the 
Anderson's eyes 
searched the films 
for volume loss, 
liquid in the pleura, 
and changes in the 
position of the 
diaphragm. 
perfusion studies accurately 
assess individual lung function 
and can be a valuable guide for 
confirming vascular patency, and 
(3) CT is an excellent method for 
assessing bronchial condition fol- 
lowing single lung transplant. 
According to Anderson, 
"Single lung transplant 
for emphysema is a tech- 
nique likely to be performed in 
many transplant centers in the 
coming decade. The results of 
our study thus far have been 
very promising, and the conclu- 
sions from the study should play 
a major role in the assessment of 
these transplants." 
Cooper agrees, "This is a 
very new field, and a diagnosis 
of possible rejection is difficult 
to obtain. This study will greatly 
enhance our general manage- 
ment of the transplanted lung, 
while affording us a reasonable 
idea of what changes can be 
expected after the operation." 
Marvin Russell considers 
himself a total success story 
"from the minute my new lung 
settled in my body and started 
breathing on its own." 
"I was in intensive care just 
two days instead of the usual 
five and stayed in the hospital 
In this computed tomography (CT) 
scan, evidence of the destruction 
caused by emphysema (shown by 
arrow) is apparent when compared 
with the healthy, transplanted right 
lung. The transplanted lung clearly 
shows branching blood vessels and 
open air passageways. 
only nineteen days," he says. "I 
was back home in Fordyce a 
month before I had planned." 
Russell feels great and attrib- 
utes his well-being to the fact 
that he follows his doctor's 
instructions to the letter. His 
regimen includes Prednisone (a 
medication to suppress rejection 
of the lung) taken twice daily, a 
special diet, an exercise pro- 
gram, and scheduled rest periods. 
Although it's been eight months 
since the transplant, Russell still 
is in a recovery period. He 
recently returned to Barnes 
Hospital for his six-month 
checkup and will return again in 
one year. All test results from 
the six-month checkup were 
good, and Russell is optimistic 
that he'll "live to a ripe old age." 
"But, if I die tomorrow, I'll 
still think it was a success," he 
adds. "Most people go from life 
to death; this new lung allowed 
me to go from death to life." □ 
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To regain mobility in her left knee, 
Marie Tarter, M.D., underwent one to 
two hours of physical therapy daily 
for six weeks. 
Joint 
Effort 
MRI Helps Diagnose 
Thousands of Sports Injuries 
Suffered by Athletes Each Year 
By Vicki Kunkler 
A year ago, Marie Tartar 
was speeding down a ski slope in Salt Lake City, 
Utah. Two miles up the mountain, she was enjoy- 
ing a good run. Within a matter of seconds, she was 
shaking off the snow and uprighting herself after 
what Tartar calls "an unlucky fall." The tumble had 
not produced agonizing pain, but, instinctively, she 
knew something was wrong. 
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Joint 
Effort 
Marie Tartar, M.D., senior 
resident at Mallinckrodt 
Institute of Radiology, 
knew her left knee had more 
play in it than it should. Luckily 
for her, and for thousands of 
other athletes—professional and 
amateur—who suffer injuries each 
year, magnetic resonance imaging 
(MRI) provides a comprehensive, 
painless way of diagnosing joint 
injuries. 
According to William G. 
Totty, M.D., associate professor 
of radiology in the Institute's 
musculoskeletal section, "Joints 
take all the stress and strain of 
our bodies. It's reasonable that 
joint injuries are going to be 
commonplace." 
Nuclear magnetic resonance 
(NMR), the forerunner of MRI, 
has been around since the 1950s 
when scientists first used mag- 
netic forces to analyze labora- 
tory chemicals. Clinical trials 
involving the MR scanning of 
human patients occurred in 
1973. Now, almost three decades 
past its inception, MRI has 
become the procedure of choice 
for diagnosing trauma-related 
disorders involving the mus- 
culoskeletal system. 
Using no ionizing radiation 
(an important aspect for 
many patients who may 
require multiple or periodic 
scans), MRI is based on interac- 
tions between a large magnetic 
field in the imaging equipment 
and atoms in the human body. 
The principle of MRI is similar to 
that of an ordinary radio, using a 
transmitter and a receiver to 
produce energy. A patient under- 
going an MR scan is placed in a 
strong magnetic field within the 
scanner. Using a transmitter, 
radio-frequency energy is trans- 
ferred to the protons in the 
patient's body. The protons then 
return the radio-frequency 
energy, which is retrieved by the 
receiver and processed with 
computers. 
MRI places few restrictions on its 
users. Because of the magnetic 
field and its effects on metal, 
patients with pacemakers or 
those who have undergone cer- 
tain types of vascular surgery 
cannot be scanned by MRI, nor 
can those patients with skull 
plates, middle-ear prostheses, 
aneurysm clips in the brain, or 
metal fragments in or about 
the eyes. 
William G. Totty, M.D., associate 
professor of radiology, in the muscu- 
loskeletal section. 
"Ml "allinckrodt Institute installed the first .of three magnetic 
resonance scanners in June of 
1983," Totty explains. "And 
we've kept them busy ever since. 
We image about four knee injuries 
per day'' 
Joseph K. T. Lee, M.D., pro- 
fessor of radiology and director 
of the magnetic resonance imaging 
section, adds, "Imaging of joints 
with MRI has really snowballed. 
Our unit puts in many extra hours 
to keep up with the requests for 
scans. The MR scanners run to 
capacity from seven in the morn- 
ing to midnight, five days a week 
and half a day on Saturday." 
As Totty points out, exact 
numbers of sports-related injuries 
are hard to predict. The term 
"sports injury" is ambiguous- 
covering the younger generation 
who are actively engaged in some 
type of sports activity, the older 
participant who is enrolled in a 
fitness program, or someone who 
had a previous sports-related 
injury and is now, perhaps years 
later, having problems. 
Most knee injuries occur in 
sports that require twisting or 
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turning, such as football (the 
most common knee injury in 
males), basketball, roller skating, 
bicycle riding, and snow skiing. 
According to the National Safety 
Council, in 1988, more than 
450,000 basketball players suffered 
some type of injury as compared 
with the 20,000 injuries asso- 
ciated with golfers. The knee is 
the largest joint in the body, a 
compound joint between the 
femur (the large bone in the 
upper leg), the patella (knee 
cap), and the tibia (the bone of 
the lower leg). Because of the 
upright nature of man, the knee 
is weightbearing and is the most 
commonly injured of all joints in 
the human body. 
Since Tartar was aware of 
her options regarding her 
injury, she went to an 
orthopedic surgeon in Salt Lake 
City as a preliminary measure. 
He outfitted her with a brace 
on her left knee and a pair 
of crutches and sent her home. 
After arriving in St. Louis, 
Tartar headed straight to the 
Institute's MRI section. She had 
no hesitation in choosing this 
diagnostic procedure. In the 
early years of Tartar's radiologic 
training, she had worked with 
numerous injured athletes, 
administering an unpleasant and 
often difficult X-ray procedure 
called an arthrogram that involves 
an injection of dye and air 
through a needle into an already 
painful joint. Then the trauma- 
tized joint is manipulated in 
order to circulate the dye. 
"Even the most physically 
large athlete would turn a little 
green when I explained that I 
had to put a needle into that knee 
of his that was already causing 
so much pain," says Tartar. 
'Add to that the fact that I 
then had to push and pull on this 
"Joints take all the 
stress and strain of 
our bodies. It's 
reasonable that joint 
injuries are going to 
be commonplace. >> 
person who weighed two times 
more than I did," she explains. 
'An arthrogram is exhausting for 
the patient and the physician." 
As Tartar points out, after 
the patient undergoes this addi- 
tional stress from arthrography, 
which can last from 35 to 45 
minutes, the downside is that 
the X ray shows only an outline 
(from the injected dye) of the 
knee structure. Arthrography 
confirms only obvious tears in 
the anterior cruciate ligaments. 
Tears or injuries of other liga- 
ments may not be imaged using 
arthrography. 
Totty agrees, "MRI does as 
well as or better than 
arthrography in imaging 
meniscal injuries. It gives a better 
look at cruciate ligament tears and 
cartilage surface abnormalities. 
MRI can clearly define not only 
those whole groups of abnor- 
malities that arthrography can 
image but also a large group of 
abnormalities that arthrography 
cannot detect, such as subtle 
fractures, ligament tears, and 
posttraumatic marrow edema or 
bone bruise." 
"But there will always be a 
need for arthrography," he adds. 
"We'll always have those groups of 
patients who can't have magnetic 
resonance—those with pacemakers 
or knee prostheses or people 
who are claustrophobic." 
MRI also has several distinct 
advantages over X rays as well as 
computed tomography (CT), a 
procedure similar to MRI. X rays 
visualize air, soft tissue, and 
bone; CT differentiates a few soft 
tissues such as tendon, muscle, 
and fluid. MRI, however, distin- 
guishes types of soft tissue even 
further: muscle, tendon, liga- 
ment, articular and fibroid car- 
tilage, fluid, fat, blood, and 
flowing blood, in addition to 
bone. 
In Marie Tartar's case, a knee 
coil, which works much like 
the antenna on your car, was 
used to obtain the best signal, 
the highest resolution, and the 
greatest amount of information 
from her injury. This coil covers 
16 centimeters. A variety of coils 
are available, like the knee coil, 
which is matched to the size of 
the body part being imaged; 
therefore, there are specific coils 
to fit the ankle, the knee, the 
shoulder, the wrist, or the head. 




The MR scan confirmed that 
Tartar had torn the major liga- 
ment in her knee, the anterior 
cruciate, which, along with the 
posterior cruciate, ties the femur 
and the tibia together and pre- 
vents friction between the 
bones. These cruciate ligaments 
work in tandem with some shock- 
absorbing padders, the crescent- 
shaped cartilage called menisci 
that are positioned between the 
bones. According to recent 
studies, the anterior cruciate 
ligament is the most frequently 
injured ligament within the 
knee, accounting for over 70 per- 
cent of cases. Oftentimes, a 
severe tear in one of the two 
ligaments in the knee also will 
result in damage to the menisci. 
Tartar now had some decisions 
to make. She could remain in the 
knee brace and see what evolved 
Three decades since 
its inception, MRI is 
the diagnostic 
procedure of choice 
for joint injuries. 
after six weeks of healing, or she 
could have the torn ligament 
surgically repaired. 
"There was always the 
chance of needing surgery even 
if I had kept the brace on for six 
weeks," said Tartar. "But I guess 
my age and high level of activity 
really steered me toward the sur- 
gery. I didn't like the idea of 
gearing down physically while 
still in my twenties." 
Tartar was hospitalized for 
two days. The surgeon har- 
vested tendon from her 
patella, tunneling the tendon 
through the femur and the tibia. 
She again was fitted with a 
brace to allow the bone and new 
ligament to incorporate. The 
brace went from midthigh to 
midcalf and kept her leg totally 
straight. Within a couple of 
weeks, Tartar graduated to a 
new brace that allowed limited 
motion. She wore the brace for 
six weeks, using crutches at 
times to relieve some of the 
stress on the knee. 
' 'The hardest part of the 
whole ordeal was after the brace 
came off," Tartar remembers. "I 
had lost the normal range of 
motion in my left knee because 
of the immobilizing effect of the 
brace. I underwent one to two 
hours of physical therapy every 
day for six weeks, including riding 
a stationary bike and some 
aerobic exercises." 
Tartar feels she's at least 90 
percent recovered. She says her 
knee is not completely as 
flexible as before the injury but 
that she has ' 'more than the 
range of motion needed for her 
normal activities." Her diagnosis 
must be accurate; this winter 
she plans to hit the slopes once 
more—hopefully, remaining 
upright the entire time. □ The MRI scan on the top shows a normal knee. The scan in the middle shows a 
medial meniscal tear (as indicated by 
the arrow). The scan on the bottom 
shows a fracture (arrows) that was 
unable to be detected by a routine 
radiograph. 
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Bahman Emami, M.D., pro- 
fessor of radiology, lectured 
on "Interstitial Thermo- 
radiotherapy in the Treat- 
ment of Malignant Tumors" 
at the Second International 
Brachytherapy and After- 
loading Symposium and 
Workshop, St. Louis, April 
19-21. Emami presented 
"Post Operative Radio- 
therapy in Non-Oat Cell 
Carcinoma of Lung" and 
"3-Dimensional Radiother- 
apy Treatment Planning of 
Lung Cancer" at the Inter- 
national Association for the 
Study of Lung Cancer, 
Brussels, June 17-21. 
Mokhtar Gado, M.D., 
professor of radiology and 
chief of neuroradiology, 
lectured on "Sellar and 
Parasellar Lesions," "Radi- 
ology of Infarction," and 
"Radiologic Manifestations 
of Demyelinating Diseases" 
at the 1990 Neuroradiology 
Review Course, Loyola Uni- 
versity, Chicago, April 
28-29. Gado presented "CT 
of the Lumbar Spine" and 
"MRI in Lumbosacral Dis- 
ease" at the Low Back and 
Sciatic Pain-Evaluation and 
Treatment Course, Wash- 
ington University School of 
Medicine, St. Louis, May 
11-12. 
Louis A. Gilula, M.D., 
professor of radiology, pre- 
sented "Imaging of the 
Painful Wrist" and "CT, 
Arthrography and MRI of 
the Wrist" as the keynote 
speaker at the combined 
meetings of the British and 
German Hand Societies, 
Stratford-upon-Avon, 
Warwickshire, England, 
May 2-5. He also co- 
organized the 6th Inter- 
national Wrist Investigator's 
Workshop, Newport Beach, 
California, May 15. 
Harvey S. Glazer, M.D., 
associate professor of radi- 
ology, lectured on "CT of 
Pulmonary Collapse" and 
"CT of the Mediastinum- 
Differential Diagnosis" at 
the 13th Annual Course of 
the Society of Computed 
Body Tomography, Palm 
Springs, April 2-6. 
Jay P. Heiken, M.D., 
associate professor of radi- 
ology and codirector of 
body computed tomography, 
lectured on "CT and MRI of 
Abdominal Vascular Disease" 
and conducted a workshop 
on "Detection of Hepatic 
Metastases: CT and MRI 
Techniques and Accuracy" 
at the 13th Annual Course 
of the Society of Computed 
Body Tomography, Palm 
Springs, April 2-6. He spoke 
on "Detection of Hepatic 
Metastases" and "MRI of 
the Pelvis" at Northwestern 
University School of Medi- 
cine, Chicago, June 20. 
Heiken and Joseph K. T. 
Lee, M.D., professor of 
radiology and director of 
magnetic resonance imaging, 
copresented an instructional 
course on "CT & MRI of the 
Retroperitoneum" at the 
90th Annual Meeting ofthe 
American Roentgen Rav 
Society,. Washington, D.C., 
May 13-18. 
Charles F. Hildebolt, 
D.D.S., Ph.D., research 
assistant professor of radi- 
ology, presented "Bitewing- 
based Determination of 
Alveolar Bone Loss" as an 
invited speaker at the 68th 
General Session of the 
International Association 
for Dental Research/19th 
Annual American Associa- 
tion for Dental Research, 
Cincinnati, March 7-11. He 
lectured on "The Future of 
Computerized Periodontal 
Disease Radiography" at 
the 90th Annual Session of 
the American Association of 
Orthodontists, Washington, 
D.C, May 5-9. 
R. Gilbert Jost, M.D., 
professor of radiology and 
chief of the Division of 
Diagnostic Radiology, lec- 
tured on "Electronic Radi- 
ology in the 1990s" at the 
Computer in Healthcare 
Conference and Exposition, 
Atlanta, May 16-18. Jost, 
who also served as an 
organizer as well as the 
scientific session and 
tutorial cochairman, 
presented "Information 
Management Systems" and 
a workshop on radiologic 
workstations at a sympo- 
sium for Computer Assisted 
Radiology, Anaheim, June 
13-16. 
Joseph K. T. Lee, M.D., 
professor of radiology and 
director of magnetic 
resonance imaging, spoke 
on "Clinical Applications of 
Fast MR Imaging" at the 
Annual Computed Body 
Tomography Society meet- 
ing, Palm Springs, April 2. 
He was a visiting professor 
at the University of Min- 
nesota, Minneapolis St. 
Paul, April 9-10; at the 
University of Michigan, 
Ann Arbor, April 16; and at 
Brown University, Provi- 
ence, Rhode Island, May 7. 
He lectured on "Chemical 
Shift Imaging of the Liver" 
at the International Liver 
Symposium, Boston, June 
25-27. 
Bruce L. McClennan, M.D., 
professor of radiology and 
director of abdominal imag- 
ing, addressed "Standards— 
What Will They Do For Us? 
What Will They Do To You?" 
at the Missouri Radiological 
Society, while serving as a 
delegate to the Missouri 
State Medical Association, 
Lake Ozark, Missouri, April 
5-8. He lectured on "Con- 
trast Material Reactions- 
Recognition and Response" 
and "Lithotripsy—Renal to 
Biliary" at the International 




& INVITED LECTURERS 
Continued from page 23. 
Special Procedures Course, 
Chicago, May 9-10. 
McClennan also presented 
a refresher course on 
"Acute Renal Infections" at 
the American Roentgen 
Ray Society, Washington, 
D.C., May 13-18. 
Stephen M. Moerlein, 
Ph.D., associate professor 
of radiology, presented two 
papers at the 137th Annual 
Meeting of the American 
Pharmaceutical Association, 
Washington, D.C., March 
10-14: "Establishment of a 
Clinical PET Facility within 
a University Teaching Hos- 
pital," coauthored with 
Michael J. Welch, Ph.D., 
professor of radiology, and 
Barry A. Siegel, M.D., 
professor of radiology and 
medicine and director of the 
Division of Nuclear Medi- 
cine; and "Radiopharma- 
ceutical Production of 
Fluorodeoxyglucose for 
Clinical PET Applications," 
coauthored with James W. 
Brodack, Ph.D., research 
assistant professor in radi- 
ology; Siegel; and Welch. 
Moerlein also lectured on 
"Heavy Radiohalogens in 
Biomedicine: Focus on 
Nucleogenic Aspects" to 
the Division of Nuclear 
Chemistry and Technology 
at the 199th American 
Chemical Society National 
Meeting, Boston, April 22-27. 
William A. Murphy, Jr., 
M.D., professor of radiology, 
spoke on "Percutaneous 
Needle Biopsy for Tumors 
and Infection in the Lumbo- 
sacral Spine" at the 
Washington University 
School of Medicine Con- 
tinuing Medical Education 
Course, St. Louis, May 11. 
He was program committee 
moderator for a session on 
"Musculoskeletal Imaging" 
at the American Roentgen 
Ray Society-Meeting, 
Washinjjton2JlC:2_May. 14. 
Robert Myerson, M.D., 
assistant professor of radi- 
ology, spoke on "Clinical 
Aspects of Regional Hyper- 
thermia" at the North 
American Hyperthermia 
Group, Hyperthermia 
School, Thomas Jefferson 
University, Philadelphia, 
May 14-15. He presented 
"Prognostic Value of Tem- 
perature and SAR Distribu- 
tion in Superficial and 
Deep Hyperthermia" at the 
5th BSD Users Conference, 
Rotterdam, Amsterdam, 
May 18-19. 
Carlos A. Perez, M.D., 
professor of radiology and 
director of the Radiation 
Oncology Center, lectured 
on "Hyperthermia" and 
"Radiation Therapy Quality 
Assurance" at the Second 
Annual Joint Conference of 
Southern California Radia- 
tion Oncology Society, 
Southern California Chapter 
AAPM, Southern California 
Endocurietherapy Society, 
San Diego, April 6-8. Perez 
spoke on "Low Dose Rate 
Irradiation of Uterine Cer- 
vix" and "Interstitial 
Irradiation in Cancer of the 
Vulva, Vagina, and Female 
Urethra" at the Second 
International Brachytherapy 
and Remote Afterloading 
Symposium and Workshop, 
St. Louis, April 19-21. He 
lectured on "General Prin- 
ciples of Radiation Therapy 
and Role in Seminoma" at 
the Surgical Urology Grand 
Rounds, Barnes Hospital, 
St. Louis, April 28, and 
presented "Current 
Management of Prostate 
Carcinoma" at the Multidis- 
ciplinary Tumor Board Con- 
ference, Barnes Hospital, 
St. Louis, April 30. Perez 
spoke on "Multidisciplinary 
Care of the Patient with 
Cancer and the Role of 
Radiation Therapy" at the 
Centro S. Pio X, Division of 
Radiation Oncology, Milan, 
Italy, May 9-10, and "Quality 
Assurance in Radiation 
Therapy: Present and 
Future Aspects," Univer- 
sity of Bologna, Italy, May 
10. He also spoke on "New 
Frontiers in Radiotherapy: 
the Role of Radiation Ther- 
apy in Small Cell Lung 
Cancer" at the Second 
International Conference 
on Small Cell Lung Cancer, 
Milano Marittima (Ravenna), 
Italy, May 11-12. He pre- 
sented "Current Status of 
Local Interstitial in Hyper- 
thermia," St. Luke's Medical 
Center, Milwaukee, May 24. 
Joseph L. Roti Roti, 
Ph.D., professor of radiol- 
ogy and chief of the cancer 
biology section, chaired a 
workshop on "Chromatin 
Damage and Repair" and a 
poster discussion on 
"Hyperthermic Sensitivity 
and Resistance: General 
and Thermotolerance and 
HSP's" as well as presented 
a poster on "Pulse-Chase, 
Post-Irradiation Studies of 
NP170 and Evidence That 
It Might Be Topoisomerase 
II" at the Radiation 
Research Society of the 
North American Hyper- 
thermia Group, New 
Orleans, April 7-11. 
Stuart S. Sagel, M.D., 
professor of radiology, 
presented "CT and MRI of 
the Hyperfunctioning 
Adrenal Mass," "CT of the 
Thymus," and "CT of 
Abdominal Lymphoma" at 
the 13th Annual Course of 
the Society of Computed 
Body Tomography, Palm 
Springs, April 2-6. 
Eric Slessinger, M.S., 
instructor in radiation 
oncology physics, spoke on 
"Quality Assurance for 
Remote Afterloading 
Devices" and conducted a 
workshop on "Radiation 
Safety and Quality Assur- 
ance in Brachytherapy" at 
the Second International 
Brachytherapy and Remote 
Afterloading Symposium 
and Workshop, St. Louis, 
April 19-21. 
Yvonne C. Taylor, Ph.D., 
assistant professor of radi- 
ology, presented "AT Cell 
Lines Demonstrate an 
Altered Radiation Response 
at the Nucleoid Level" at the 
Radiation Research Society, 
New Orleans, April 7-11. 
Michael W. Vannier, M.D., 
professor of radiology and 
director of the image pro- 
cessing laboratory, spoke 
on "Modern Imaging Tech- 
niques for the Assessment 
of Craniofacial Deformities" 
at The Development and 
Treatment of Cranial Defor- 
mities Symposium, Univer- 
sity of Alberta, Edmonton, 
Alberta, Canada, April 26. 
He also lectured on "Three- 
Dimensional Biomedical 
Imaging" at an Electrical 
Engineering Seminar, 
University of Alberta, April 
27. Vannier presented a 
research seminar, "Three- 
Dimensional Biomedical 
Imaging Research," at the 
Washington University 
School of Medicine Radia- 
tion Oncology Center, Sec- 
tion of Cancer Biology, St. 
Louis, May 8. He presented 
the keynote address, 
"Exploring Today's New 
Frontiers and Future Pro- 
jections: Three Dimensional 
Biomedical Imaging," at the 
16th Canadian Medical and 
Biological Engineering Con- 
ference and the 25th Anni- 
versary of the Formation of 
the Canadian Medical and 
Biological Engineering 
Society, Winnipeg, 
Manitoba, June 10-12. 
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The following Mallinckrodt 
Institute staff members 
participated in the 37th 
Annual Meeting of The 
Society of Nuclear Medi- 




Edward M. Geltman, M.D., 
"Use of Intravenous Dipyri- 
damole and Dobutamine in 
Lieu of Exercise for Evalu- 
ation of Myocardial Perfusion 
and Metabolic Reserve." 
Andrea H. McGuire, M.D., 
"Radiolabeled Steroid 
Receptor Ligands in 
Oncology." 
Stephen M. Moerlein, 
Ph.D., "Recent Develop- 
ments in PET Radio- 
pharmaceuticals.' ' 
Marcus A. Raichle, M.D.; 
Joel S. Perlmutter, M.D.; 
William J. Powers, M.D., 
"The Role of PET in Neuro- 
logical Research and 
Diagnosis." 
Henry D. Royal, M.D., 
"Nuclear Accident 
Management." 
Michel M. Ter-Pogossian, 






Susan Madsen, M.A.; 
Michael J. Welch, Ph.D.; 
Robert A. Weisman, Ph.D.; 
Ramunas J. Motekaitis, 
Ph.D.*; Arthur E. Martell, 
Ph.D.*, "Synthesis and 
Investigation of N,N,N',NL 
Tetrakis-Ethylenediamine: 
A Potential Generator Pro- 
duced Tracer for PET Imag- 
ing." * Department of 
Chemistry, Texas A&M 
University, College Station. 
Stephen M. Moerlein, 
Ph.D.; Alan Daugherty, 
Ph.D.; and Michael J. 
Welch, Ph.D., "Assessment 
of In-Vivo Lipoprotein 
Metabolism with Ga-68 and 
In-Ill Labeled Low-Density 
Lipoprotein." 
Landis K. Griffeth, M.D.; 
Farrokh Dehdashti, M.D.; 
Andrea H. McGuire, M.D.; 
David J. Perry, C.N.M.T.; 
Stephen M. Moerlein, 
Ph.D.; and Barry A. Siegel, 
M.D., "PET Evaluation of 
Soft-Tissue Masses with 
F-18 Fluorodeoxyglucose." 
Stephen M. Moerlein, 
Ph.D., and Joel S. 
Perlmutter, M.D., "Evalu 
ation of N-W-F-18-Fluoro- 
ethylketanserin for Measure- 
ment of In-Vivo S-2 Receptor 
Binding with PET." 
Dah-Reh Hwang, Ph.D.; 
Carla J. Mathias, B.A.; 
Michael J. Welch, Ph.D.; 
Andrea H. McGuire, M.D.; 
and Dov Kadmon, Ph.D.*, 
"Imaging Prostate Derived 
Tumors with PET and N-(3- 
F-18 Fluoropropyl) Putres- 
cine." * Baylor College of 
Medicine, Houston. 
Dah-Reh Hwang, Ph.D.; 
Carla J. Mathias, B.A.; 
Michael J. Welch, Ph.D.; 
John Lloyd Ph.D.*; Edward 
W. Petrillo, Ph.D.*; William 
C. Eckelman, Ph.D.*, "Syn 
thesis and Biodistribution 
of F-18 -Labeled Angiotensin 
Converting Enzyme Inhibi- 
tor." * Squibb Institute for 
Medical Research, Princeton, 
New Jersey. 
Dah-Reh Hwang, Ph.D.; 
Carmen S. Dence, M.S.; 
Carla J. Mathias, B.A.; 
Zoe A. McKinnon, B.S.; 
and Michael J. Welch, 
Ph.D., "F-18-Labeled Mus- 
carinic Acetylcholine 
Receptor (mAChR) Ligands. 
Synthesis and Biodistribu- 
tion of 2- and 4- F-18 
Fluorodexetimide (FDEX)." 
Farrokh Dehdashti, M.D.; 
Andrea H. McGuire, M.D.; 
Henry F. VanBrocklin, 
M.S.; James W. Brodack, 
Ph.D.; Dorothy P. Andri- 
ole, M.D.;Carla J. 
Mathias, B.A.; Barry A. 
Siegel, M.D.; Michael J. 
Welch, Ph.D.; Martyn G. 
Pomper, B.S.*; and John 
A. Katzenellenbogen, 
Ph.D.*, "Assessment of 
Progestin Receptors in 
Breast Carcinoma by Posi- 
tron Emission Tomography." 
♦Department of Chemistry, 
University of Illinois, Urbana. 
Carla J. Mathias, B.A.; 
Michael J. Welch, Ph.D.; 
Mark A. Green, Ph.D.*; 
Claude F. Meares, Ph.D.* *, 
"In Vivo Comparison of 
Copper Blood Pool Agents: 
Potential Radiopharmaceu- 
ticals for Use With Copper- 
62." * School of Pharmacy, 
Purdue University, West 
Lafayette, Indiana; ** Uni- 
versity of California, Davis. 
Mark A. Green, Ph.D.*; 
Michael J. Welch, Ph.D.; 
Carla J. Mathias, B.A.; 
Steven R. Bergmann, M.D., 
Ph.D.; Joel S. Perlmutter, 
M.D.; Marcus E. Raichle, 
M.D.; Frankee Rubio, 
Ph.D.**; and Michael 
Janik, B.S.**, "Copper-62- 
PTSM: Production and Eval- 
uation of a Generator- 
Produced Multi-Purpose PET 
Perfusion Agent." * School 
of Pharmacy, Purdue Uni- 
versity, West Layfayette, 
Indiana; ** Mallinckrodt 
Medical Inc., St. Louis. 
Jerold W. Wallis, M.D., 
"Three Dimensional Dis- 
play in Nuclear Medicine" 
and "Volume Rendering in 
the Three-Dimensional Dis- 
play of SPECT Images." 
POSTER 
PRESENTATIONS 
Henry F. VanBrocklin, 
M.S.; James W. Brodack, 
Ph.D.; Carla J. Mathias, 
B.A.; Michael J. Welch, 
Ph.D.; John A. Katzenellen- 
bogen, Ph.D.*; James F. 
Keenan, Ph.D.* *; Gerald J. 
Mizejewski, Ph.D.**, "Age 
Dependence of the Alpha- 
Fetoprotein 16-F-18 Fluoro- 
estradiol (FES) Interaction 
in Female Rat Serum." 
* Department of Chemistry, 
University of Illinois, 
Urbana; **New York State 
Department of Health, 
Albany. 
Stephen M. Moerlein, 
Ph.D., "N-w- F-18 
Fluoroalkylated Flumazenil: 
Potential Agents for Mapping 
Cerebral Benzodiazepine 
Receptors with PET." 
Michael J. Welch, Ph.D.; 
Mark A. Green, Ph.D.*; 
David J. Perry, C.N.M.T; 
Andrea H. McGuire, M.D.; 
Shirley X. Zhu, Ph.D.**; 
Judy M. Connett, Ph.D.* *, 
"Copper-PTSM Measures 
Tumor Blood Flow, Too!" 
* School of Pharmacy, Purdue 
University, West Lafayette, 
Indiana; * Mewish Hospital, 
St. Louis. 
Robert A. Weisman, Ph.D.; 
Stephen M. Moerlein, 
Ph.D.; Julie A. Sahakian, 
B.S.; Michael J. Welch, 
Ph.D.; JillC. Merrill, 
Ph.D.*; Albert P. Li, Ph.D.*, 
"Metabolism of N-Isopropyl- 
P-Iodoamphetamine (IMP) 
by Cultured Rat Liver 
Cells." * Environmental 
Health Lab, Monsanto Com- 
pany, St. Louis. 
WORKS IN PROGRESS 
Dah-Reh Hwang, Ph.D.; 
Jialing L. Gong, Ph.D.; 
Michael J. Welch, Ph.D., 
"Positron-Labeled Monoa- 
mine Oxidase Inhibitors: 
Synthesis of Fluoropargy- 
line and Propargylamine." 




Judy Destouet, M.D., 
associate professor of radi- 
ology and head of mammog- 
raphy, was appointed chair- 
person of the Ad Hoc Com- 
mittee on Women's Issues 
for the American Associa- 
tion of Women Radiologists 
G. Leland Melson, M.D., 
professor of radiology and 
chief of diagnostic ultra- 
sound, was appointed to a 
three-year term as vice 
president of the Washington 
University Chapter of 
Alpha Omega Alpha, a 
medical honor society. 
William A. Murphy, Jr., 
M.D., professor of radiology, 
was appointed chairman of 
Bone Disease V Syllabus 
for the American College of 
Radiology's Professional 
Self-Evaluation and Con- 
tinuing Education Program. 
Carlos A. Perez, M.D., 
professor of radiology and 
director of the Radiation 
Oncology Center, was an 
appointed examiner for the 
American Board of Radiology 
Oral Examination held in 
Louisville, June 4-8. 
Joseph L. Roti Roti, Ph.D., 
professor of radiology and 
chief of the cancer biology 
section, was recently 
appointed to the North 
American Hyperthermia 
Group Advisory Board for 
the 6th International Con- 
gress on Hyperthermic 
Oncology and also was 
appointed chairman of the 
Cyclotron ALARA Subcom- 
mittee. 
Barry A. Siegel, M.D., 
professor of radiology and 
medicine and director of 
the Division of Nuclear 
Medicine, was appointed 
secretary of the American 
Board of Nuclear Medicine 
during his sixth and final 
year as an active member 
of the Board. He also is 
chairman of the examina- 
tion committee for the 
1990 Nuclear Medicine cer- 
tifying examination. 
Michael W. Vannier, M.D., 
professor of radiology and 
director of the image pro- 
cessing laboratory, was 
appointed to the editorial 
board of Investigative 
Radiology—A Journal of 
Clinical and Laboratory 
Research, which is the offi- 
cial publication of the 
Association of University 
Radiologists, the Society of 
Chairmen of Academic 
Radiology Departments and 
the American Association 
of Academic Chief Resi- 
dents in Radiology. 
HONORS/AWARDS 
GRANTS/FELLOWSHIPS 
Joseph L. Roti Roti, Ph.D., 
professor of radiology and 
chief of the cancer biology 
section, is principal investi- 
gator for a $3 million pro- 
gram project grant awarded 
by the National Institutes 
of Health (NIH). The five- 
year study, "Nuclear Deter- 
minants of Therapeutic 
Response," is aimed at 
unlocking the mechanisms 
of radiation-induced cell 
killing at the molecular 
level. Roti Roti and project 
leaders Leonard J. Ibl- 
mach, Ph.D.; Yvonne C. 
Taylor, Ph.D.; and Andrei 
Laszlow, Ph.D., will focus 
on a more effective way to 
determine how certain 
cancer cells should be 
treated and which therapy 
would be most beneficial in 
destroying the cancerous 
cells. 
Henry F. VanBrocklin, 
M.S., graduate student, 
received an appointment in 
the Alexander Hollaender 
Distinguished Postdoctoral 
Fellowship Program, which 
is supported by the U.S. 
Department of Energy, 
Office of Health and 
Environmental Research. 
TECHNOLOGIST NEWS 
Cynthia K. Daniels, R.T., 
B.S., assistant program 
director in radiography, 
was elected treasurer of 
the Missouri Society of 
Radiologic Technologists at 
the 58th Annual Conference, 
Springfield, Missouri, May 
16-19. 
Michael Hoxsey, Kevin 
Peterson, and Gordon 
Wheeler, MIR radiography 
students, won first place in 
the Third Annual Student 
Bowl Competition while 
attending the 58th Annual 
Conference of the Missouri 
Society of Radiologic Tech- 
nologists in Springfield, 
Missouri, May 16-19. 
Johnnie B. Moore, R.T., 
B.S., program director in 
radiography, and Cynthia 
K. Daniels, R.T., B.S., 
assistant program director 
in radiography, participated 
in the St. Louis Public 
Schools' Career Awareness 
Fair, May 1-2. 
Carolyn J. Offutt, R.T., 
B.A., research technologist, 
coauthored an article 
entitled " Volumetric 3-D 
Imaging of Computerized 
Tomography Scans" with 
Michael W. Vannier, M.D.; 
Louis A. Gilula, M.D.; 
Jeffrey L. Marsh, M.D.; 
and Charles J. Sutherland, 
M.D. The article appeared 
in Radiologic Technology, 
Volume 61, No. 3. 
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FYI 
Michael D. Ward, R.T., 
M.Ed., FASRT, chief tech- 
nologist and director of 
technical education, spoke 
on "Medical and Legal 
Aspects of Radiology" at 
the Jacksonville Society of 
Radiologic Technologists, 
Mayo Clinic, Jacksonville, 
Florida, April 19, and at 
the Baptist Medical Center, 
Jacksonville, April 20. He 
was inducted into Pi Lambda 
Theta, the national honor 
and professional associa- 
tion in education, St. Louis 
University, May 10. Ward 
presented "Never, Never, 
Never Give Up Your Dreams" 
at the 4th Annual Ulysses 
D. Murray Lecture while 
attending the 58th Annual 
Conference of the Missouri 
Society of Radiologic Tech- 
nologists, Springfield, 
Missouri, May 16-19. 
The following MIR radiog- 
raphy students received 
honors in the student exhibit 
category of the Missouri 
Society of Radiologic Tech- 
nologists exhibit competi- 
tion: Michael Hoxsey and 
Kevin Peterson won first 
place for their entry, "New 
Attack for Arterial Plaque;" 
second place went to 
Gordon Wheeler and Kurt 
Basler for their exhibit, 
"3-D Reconstruction of CT 
and MRI Scans;" and third 
place was awarded to Edith 
Hartmann, Kimberly 
Frkovich, Lisa Hatcher, 
and Melinda Wendle for 
"Don't Panic-PET Is Here." 
CIC 
NEWS 
The Cancer Information 
Center (CIC) is cosponsored 
by the Mallinckrodt Institute 
of Radiology, the Barnard 
Free Skin and Cancer 
Hospital, and Barnes 
Hospital at the Washington 
University Medical Center. 
CONTRIBUTIONS 
Mary Holtsclaw in memory 
of Jack Bresnahan 
Rachel S. Harder in 
memory of Jack Bresnahan 
Mary Ann Gilroy in 
memory of Clarence R. 
Delaney 
Lois Brown in memory of 
Viola Soloman 
Mr. and Mrs. Richard J. 
Meyer in memory of George 
Leathers 
Logica Data Architects, Inc. 
in memory of Paul Dunn 
Mr. and Mrs. Sam 
Budrovich in memory of 
George C. Braun 
Mrs. Estelle Wolff in 
memory of Ralph Laughlin 
Elizabeth Kelledy Dubin 
and Annora Kelledy Koetting 
in memory of William L. 
Farrelly 
Elizabeth B. Spataro in 
memory of William L. 
Farrelly 
Dolores J. Kozacka 
Mrs. W. Milner Donovan in 
memory of William L. 
Farrelly 
Mrs. Arthur C. Hiemenz in 
memory of William L. 
Farrelly 
John T. Dillion in memory 
of Helen M. Boshard 
Linda S. Penniman in 
memory of William L. 
Farrelly 
Dr. and Mrs. William Reinus 
in memory of William L. 
Farrelly 
John M. Drescher, Jr. in 
memory of William L. 
Farrelly 
Mr. and Mrs. Thomas R. 
Remington in memory of 
William L. Farrelly 
Catherine F. Hoopes in 
memory of William L. 
Farrelly 
Beverly K. Fogelman in 
memory of William L. 
Farrelly 
Henry, Bernie and Hank 
Belz in memory of William 
L. Farrelly 
Gretchen H. Ross in 
memory of Hilda Krieser 
Marcel Petrovic in memory 
of Clarence Brand 
Richard W. Hagedorn in 
memory of William L. 
Farrelly 
Audrey Hixson in memory 
of Donald "Ed" Baker 
Reta Patterson in memory 
of Donald "Ed" Baker 
Mr. and Mrs. Alexander 
Cornwell in memory of 
William L. Farrelly 
John M. Drescher, Jr. in 
memory of Edward L. 
Keyes, Sr. 
Barbara Bilgram O'Brien in 
memory of Nancy Bobbitt 
Davis 
Gloria J. Pemberton 
Mrs. Arthur C. Hiemenz, Jr. 
in memory of Dr. E. 
Lawrence Keyes 
Karen D. Greening in 
memory of William L. 
Farrelly 
Mary Carolyn Burkemper 
in memory of William L. 
Farrelly 
Mary Helen Sullivan in 
memory of William L. 
Farrelly 
Mr. and Mrs. Alexander 
Cornwell, Jr. in memory of 
Dr. E. Lawrence Keyes 
Staff of 12100-Barnes 
Hospital in memory of 
George Gearin 
Diana Spener Dickes in 
memory of William L. 
Farrelly 
Mrs. Frederick Hermann in 
memory of William L. 
Farrelly 
Mrs. Frederick Hermann in 
memory of Elizabeth Burns 
Mrs. Frederick Hermann in 
memory of Maie Schlafly 
Mrs. Frederick Hermann in 
memory of Dr. E. Lawrence 
Keyes 
Mrs. Frederick Hermann in 
memory of Mrs. Duncan 
Bauman 
Mrs. Beulah M. Ursini in 
memory of Kathryn Shaw 
Pam and Jim Bowman in 
memory of Abbey 
Kurlander 
Mrs. RuthE. Smith in 
memory of Helen 
Cunningham 
Mr. and Mrs. Donald 
Murray in honor of Mrs. 
Aubuchon 
Mr. and Mrs. Bud Stark in 
memory of Marie Lipka 
William Shannahan 
Eula McMurray 
Tamara Rhomberg in 
memory of Esther Bellestri 
Shotsy Maylon in memory 
of Esther Bellestri 
Dorothy Tuttle in memory 
of Helen A. Eichstadt 
Mr. and Mrs. Jeffrey C. 
Larrich in memory of 
Eunice Wright 
Mr. and Mrs. Leon Axley in 
memory of Betty Schulte 
Stephen and Beth Block in 
memory of Sandy Kahn 
Occupational Therapy Club 
at Meramec Community 
College in memory of 
Lorraine Fuhrman 
Robert E. Burns in memory 
of Elizabeth Nolker Burns 
Shelly Lindell 
Gretchen Ross in memory 
of May Scofield 
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Gladys M. Hogan in 
memory of Bernice 
Winheim 
Bailey, Banks, and Biddle 
Store in memory of Mrs. 
Sandra Kahn 
Mr. Frederick Jenkins in 
memory of Wilma C. 
Jenkins 
Mr. and Mrs. William 
Phillips in memory of 
Glenn Moss 
Mr. and Mrs. Ed Henry in 
memory of Glenn Moss 
Mr. and Mrs. James Fleming 
in memory of Monte 
Strub, Sr. 
Mr. and Mrs. Tom 
DeBenedetti in memory of 
Mrs. Schlaterbeck 
Eleanor Isbell in memory 
of Bernice Mocere 
Mrs. Eghigian 
Mr. and Mrs. Joseph Basta 
in memory of John Kilgalen 
Irma and Raymond Scholle 
in memory of Irma Baugh 
First Presbyterian 
Church—Stephan Ministry 
Mr. and Mrs. Stanley Stuart 
in memory of Elizabeth 
Johns 
Ms. Melba C. Kilian in 
memory of John Kilgalen 
Mr. and Mrs. Ronald Kaiser 
in memory of Irma Baugh 
Mr. and Mrs. Harold 
Garfield in memory of Flor- 
ence Klayman 
Thelma Overall in memory 
of July Ryan 
Mr. and Mrs. Alexander L. 
Keyes in memory of Dr. E. 
L. Keyes 
Mr. and Mrs. Leonard H. 
Eatherton in memory of 
Marshall Fisk 






Ronald G. Evens, M.D., direc- 
tor of the Institute, (right) 
welcomes Virgil Loeb, Jr., 
| M.D., past president of the 
x
 American Cancer Society, to 
j?  the Breast Diagnostic Center 
o  Open House on May 8, 1990. 
CALENDAE 
August 4-8, 1990 




August 4-5; October 6-7, 
1990 
Complete Breast Imaging 
for the Technologist 
Rochester, New York 




August 18-24, 1990 
Society of Magnetic 
Resonance in Medicine 
New York City 
September 10, 1990 
19th Annual Wendell C. 
Scott Lecture 




September 17-21, 1990 
MR Imaging Fellowship 
Magnetic Resonance Imaging 
Education Foundation 
Cincinnati 
September 19-21, 1990 
Interventional Radiology/ 
2nd Marmara Medical Days 
Istanbul 
September 21-27 
American College of 
Radiology 
Nashville 
Judy Destouet, M.D., (left) 
and Dorothy P. Andriole, M.D. 
September 23-30, 1990 
12th Annual International 
Radiology Congress 
Eastbourne, Sussex, 
England and Brussels, 
Belgium 
September 27-28, 1990 




October 1-5; December 
3-7, 1990 
Postgraduate Workshops in 
MR Imaging 
Baylor College of Medicine 
Houston 
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October 5-8, 1990 
5th Annual Imaging Seminar 
University of Vermont 
Stowe 
October 6-13, 1990 
15th Annual International 
Body Imaging Congress 
Kauai 
Michaele Gold, director of 
public relations and mar- 
keting (right), was on hand 
to greet William Berman, 
M.D., and Kathy Poole, 
administrative coordinator 
of Midwest Breast Care Center. 
October 11-14, 1990 
4th Annual American 
Lithotripsy Society Meeting 
San Diego 
Judy Destouet, M.D., head of 
mammography, explains the 
workings of the Breast Diag- 
nostic Center's stereotaxic 
fine needle biopsy system. 
October 14-19, 1990 
Society for Radiation 
Oncology Administrators 
Miami Beach 
October 15-19, 1990 
American Society for 
Therapeutic Radiology and 
Oncology 
Miami Beach 
October 15-20, 1990 
Association of Residents in 
Radiation Oncology 
Miami Beach 
November 2-4, 1990 
ACR Symposium on 
Mammography 
Boston 
November 25-30, 1990 





Please help us locate the 
following alumni. If you 
have an address or phone 
number for anyone on this 
list, drop us a line at the 
Office of Public Relations 
and Marketing, Mallin- 
ckrodt Institute of Radiology, 
510 South Kingshighway, 
St. Louis, Missouri 63110 
or call (314) 362-2866. 
Dr. Roger Adams 
Dr. Ellen G. Archer 
Dr. Robert G. Armbruster 
s Dr. Raghavan Balachandran 
£ Dr. Robert G. Bartsch 
| Dr. Carole Benbassat 
o 
z
 Dr. Robert L. Bevier 
Dr. David Bookin 
Ms. Sherry S. Breaux 
Dr. Amy L. Bronson 
Dr. Terrance A. Brown 
Miss Nancy Jo Caston 
Dr. Tze-Chun Chiang 
Dr. Ben D. M. Chen 
Mrs. Maria Chraplyvy 
Mr. David C. H. Chung 
Dr. Stanley Cohen 
Dr. R. A. Collet 
Mr. Dean M. Coulter 
Dr. Hollace L. Cox, Jr. 
Dr. Adrian H. Dahl 
Dr. Andrzej Demidecki 
Dr. Erich J. Diamant 
Dr. Rafael Ducos 
Dr. Mark Edelstein 
Dr. Robert M. Evans 
Dr. Patricia Ann Farih 
Dr. Dagmar Flentje 
Dr. Michael Flentje 
Dr. Ernest Franklin 
Dr. H. W. Fulbright 
Dr. John C. Georgian 
Dr. Howard Gest 
Mr. John Glover 
Dr. Mark Green 
Dr. Otto H. Grunow 




Continued from page 29. 
Dr. Corrado Gurgo 
Ms. Kathryn A. Hackman 
Dr. Sheri D. Henderson 
Dr. Robert M. Hochmuth 
Dr. Chi Soon Im 
Mrs. Somlak Intarasupht 
Dr. William Ittner 
Dr. Katherin A. Jacobs 
Ms. Janet A. Johnson 
Dr. Terence Jones 
Dr. Tu-Shan Jung 
Dr. Bruni O. Junnila 
Dr. Herman Kalckar 
Dr. Suk Hee Kim 
Dr. Walter J. Kopecky, Jr. 
Mr. Ken Krippner 
Dr. Kenneth Krohn 
Dr. Stephen J. Kuo 
Dr. Daniel J. Landiss 
Dr. Alexander S. Langsdorf 
Dr. Jae Mun Lee 
Dr. Ori Lerman 
Mr. Rudolfo Velasco Lezama 
Dr. Duan Liang 
Ms. Judith Arlene Lifton 
Dr. Bo-Qi Liu 
Mr. Chi-Ching Lo 
Mr. John F. Lontz 
Dr. Delmar H. Mahrt 
Dr. Benedict P. Mariano, Jr. 
Dr. Alfredo Mauri-Crespo 
Dr. Bert Maxwell 
Dr. Gaellan Mcllmoyle 
Dr. Abbe D. Mendlowitz 
Dr. Juan Monge 
Dr. Anthony Morrissey 
Dr. Teresa Murrillo 
Dr. Yuzuru Nakamura 
Dr. Jack W. Newton 
Dr. David Oliver 
Dr. Judith G. Olson 
Dr. Ralph Overman 
Dr. Kalman Palmer 
Dr. Sivarajan Pandian 
Dr. Timothy B. Patrick 
Dr. Robert A. Phillips 
Dr. Platt 
Dr. Wilburg Pokorny 
Dr. Stanley L. Ranson 
Captain Glen Reeves 
Dr. Huibert S. Reinhold 
Mr. Cabrera Jose Enrique 
Rivena 
Dr. Ernesto H. Roesler 
Dr. Sanford Rudman 
Dr. Indulal Rughani 
Dr. James E. Russell 
Dr. Giovanni R. Santelli 
Dr. Vythialingam 
Sathiaseelan 
Miss Aleene K. Schneider 
Dr. James D. Schroering 
Ms. Joanne Schott 
Dr. Giles A. Sexton 
Dr. Kay E. Shumate 
Dr. Ellen Evans Smith 
Dr. Arkady Smolin 
Dr. Y. C. Soo 
Dr. William W. Stanbro 
Dr. Steven Stokes 
Dr. Eugenio Suarez 
Dr. Stephen Szeepe 
Mr. Kazuhiro Takahashi 
Dr. Chang-Shih Tai 
Dr. John D. Tarling 
Dr. Peter D. Thomas 
Dr. Robert L. Thornton 
Ms. Sandra Jean Tolen 
Dr. Bernardus Van der Zeijst 
Dr. Leo P. Vernon 
Ms. Sally J. Wagner 
Dr. Richard F. Wallin 
Dr. B. W. Wieland 
Dr. Harry William Wiese 
Dr. Shing-Erh Yen 




We want to hear 
from you so we can 
share your news with 
your colleagues and 
friends. Please take a 
moment to fill in the 
form below and return 
it to Mallinckrodt 
Institute of Radiology, 
Public Relations and 
Marketing, 510 
South Kingshighway, 





WHERE I CAN BE REACHED: 
TELEPHONE #: 
HERE IS THE NEWS I WANT TO SHARE: 
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RONALD   G.    EVENS,    M. D.,    DIRECTOR 
After serving a two-year term as 
Washington University's vice chan- 
cellor for financial affairs, Ronald 
Evens returned full-time to MIR on 
June 1. We welcome him back knowing 
full well he'll be off and running 
again. In fact, he's taken on five new 
appointments in the last six months 
in exchange for his "retirement" from 
the University's financial affairs. 
The National Institutes of Health 
(NIH) has appointed him to two 
positions: as an evaluator of radiol- 
ogy research for NIH and to the exec- 
utive committee for a consensus 
conference on low osmolality contrast 
media. Evens also was appointed to 
the executive committee for the 
National Science Foundation's sym- 
posium on PACS. In addition, he was 
appointed a member of the board of 
directors of IMCERA, the parent 
company of Mallinckrodt, Inc., and 
to the editorial board of JAMA. 
Widely regarded as an authority 
in the field of socioeconomics in 
medicine, Evens often is called upon 
for his expertise by medical centers, 
universities, governmental organi- 
zations and private industry. 
The following article, published in 
the June 1990 issue o/Radiology Today, 
is an excerpt from Evens' discussion, 
called "The Need for Cost/Benefit 
Analysis in Diagnostic Imaging," at 
the National Conference on Advances 
in Cancer Imaging. 
—Michaele Gold, Executive Editor 
In today's complicated world, 
nothing is excluded from eco- 
nomic evaluation, including 
politics, religion, education, and 
most aspects of an individual's 
life. Why should medicine be any 
different? 
Resources are limited, diag- 
nostic and treatment procedures 
are often expensive, and finan- 
cial planning is essential to most 
successful projects. During the 
1980s, economic evaluation of 
medical care has become more 
sophisticated, more scientific, 
and more valuable. 
Cost/benefit analysis is an 
effective model for economic 
research. However, defining 
costs and benefits is not easy in 
practice. I would suggest that 
both terms have three tiers of 
analysis, with each higher level 
being more specific, more useful, 
and more difficult to study. 
DEFINING "BENEFIT" 
On the benefit side of the 
equation, the first tier is an 
evaluation of patient safety: how 
safe is a new procedure, and how 
does its safety compare to cur- 
rently available diagnostic or 
therapeutic procedures? 
Standard procedures are 
available to evaluate the safety 
of a new technology. Today it is 
highly likely that, when a new 
technology is accepted for clinical 
use, it is "safe," meaning that its 
risk is reasonable in comparison 
to currently available procedures. 
Credit goes to many individuals 
and organizations in setting high 
standards for patient safety. 
The second tier of patient 
benefit is one of function: does 
the procedure work as it is sup- 
posed to work? 
Again, the state of the art is 
quite good; for most technologies, 
there are standard mechanisms 
and methods to answer this 
question that are well known to 
academicians. Appropriate pro- 
tocols may be costly in time and 
money, but we can answer the 
question with confidence. 
The third tier of benefit anal- 
ysis addresses efficacy: is the 
procedure useful? 
Pretty pictures are not neces- 
sarily useful; a new contrast 
agent may identify the kidneys, 
but may not be more efficacious 
than other agents. There are 
many examples of technologies 
that perform as expected, but 
are not medically useful. For 
instance, in breast imaging we 
have thermography and diapha- 
nography, which give us colorful 
images of anatomy and physiology, 
that are not useful because they 
do not differentiate benign from 
malignant lesions nor satisfac- 
torily detect small lesions. Unfor- 
tunately, we are not very good at 
defining efficacy. 
DEFINING "COST" 
On the other hand, the first 
tier of cost analysis answers the 
question of straight expense: 
how much does it cost? 
This is the equivalent of the 
first-tier question of benefit: is it 
safe? It is the first level of eco- 
nomic evaluation and a rela- 
tively straightforward analysis. 
Whether focusing on a specific 
procedure (e.g., CT) or its appli- 
cation to a specific disease (e.g., 
CT of lung cancer), we are rea- 
sonably confident in analyzing 
the variables that are important 
to cost, such as procedure, 
volume and geographic location. 
The second, more serious 
cost analysis tier is cost- 
effectiveness. This tier raises 
contingent issues such as the 
social impact of a disease. Cost- 
effectiveness analysis should 
measure the net cost of providing 
a service (expenditures minus 
savings) in terms of dollars, and 
compare this cost to a unit of 
benefit (e.g,. number of cancers 
found, five-year survival rate, or 
quality adjusted life years of 
survival). 
While a single procedure may 
be subjected to cost-effectiveness 
research, the analysis becomes 
more powerful when comparing 
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alternative procedures or pro- 
grams. Ideally, cost-effectiveness 
analysis should be used to study 
final outcomes, such as years of 
life saved. However, in many 
cases it is impossible to measure 
final outcomes, and intermediate 
health outcomes (e.g., diagnoses 
made or cancers found), or other 
methods to translate intermediate 
results into longer range outcome 
analysis may be substituted. 
The third and highest tier of 
cost analysis is cost/benefit 
itself: given the net cost of a par- 
ticular outcome, is the outcome 
worth the cost? 
In order to make this deci- 
sion, both the cost and the 
benefit ideally should be meas- 
ured in the same units, usually 
dollars. Thus, the benefit or out- 
come (such as breast cancers 
found, lives saved, or quality 
years of life added) must now be 
translated into dollar terms. How 
valuable in dollars is finding a 
breast cancer or extending a life 
for five years? 
Economic studies at this level 
of sophistication have rarely 
been performed with diagnostic 
radiology or radiologic thera- 
peutic procedures. There are many 
reasons for not performing this 
third tier of analysis, including 
the complexity of the analysis, 
the difficulty in translating out- 
comes to dollars, and the sensi- 
tivity of the contingent social 
and political issues. 
THE USE OF 
COST/BENEFIT ANALYSIS 
If the results of cost/benefit 
analysis were available, then 
important medical policy decisions 
could be made across medical 
disciplines and diseases. For 
example, should limited resources 
be spent on trauma patients, or 
patients with cancer, or patients 
with AIDS? 
Cost/benefit analysis could 
also be used to answer certain 
"guns or butter" decisions. For 
example, if we have sizable 
reductions in defense spending 
over the next decade, should this 
money be utilized to reduce the 
national debt, support medical 
research, provide diagnostic and 
therapeutic resources for cancer 
patients, or be spent on other 
important social issues (e.g., 
crime prevention or home- 
lessness)? 
Unfortunately, satisfactory 
cost/benefit data are not avail- 
able for most issues. We are for- 
tunate if data is available to 
determine that a procedure is 
safe, works as expected, costs a 
certain amount, and is cost- 
effective. Only a limited number 
of procedures have undergone a 
true cost/benefit analysis. 
SHALL WE? 
Is it worth the time and 
effort to perform cost/benefit 
analyses for diagnostic proce- 
dures? There is a double cost to 
such analysis: time and money. 
The potential advantage is 
improved patient care at reason- 
able cost. However, beyond 
improving the medical care of a 
particular primary cancer or use 
of a diagnostic procedure, the 
goal should be establishing 
rational public policy for the 
1990s. The percentage of our 
gross national product and total 
dollars available for medical care 
have some limit, and scientists 
and clinicians should be 
interested in developing a 
rational approach for spending 
this money wisely. 
The uses of specific diagnostic 
procedures in specific cancers 
are major cancer care issues, for 
example, but broader public policy 
questions will ultimately be more 
important. Such public policy 
issues for cancer care are: 
■ apportioning funds for 
research versus screening versus 
patient management 
■ apportioning funds for cancer 
versus other diseases 
■ selecting the site for screening: 
hospital versus physician's office 
versus "center" 
■ using a single modality versus 
multiple modalities. 
All clinicians should be inter- 
ested in efficacy, whether in 
screening, diagnosis/staging, or 
follow-up. D. M. Eddy has shown 
how a cost/benefit analysis can 
identify when a longer time 
between repeat procedures (Pap 
smears for cervical cancer) can 
reduce cost without any reduc- 
tion in benefit. He shows that an 
annual Pap smear can be changed 
to a study every second or third 
year with only minimal reduc- 
tion in cancer detection (from 
100% to 97%). Similar reductions 
in ordering diagnostic imaging 
procedures could save millions of 
dollars. 
However, even when appro- 
priate cost/benefit data are avail- 
able, are medical practitioners 
willing to listen and act? Medical 
practice patterns are difficult to 
change; physicians are interested 
in providing "the best" care for 
their individual patients, and 
they resist compromising what 
they believe to be "the best" on 
the basis of data derived from 
studies that show some (perhaps 
little) benefit despite high cost. 
Increasing concern about 
medical cost and increasing use 
of cost/benefit analysis will make 
it more likely that future tech- 
nologies will have evaluation 
prior to routine use. Money does 
talk, and it will talk with an 
increasingly louder voice. In 
order to influence medical care, 
the clinical and scientific com- 
munity must be willing to sup- 
port and require appropriate 
cost/benefit analysis research. 
Physicians have been suspicious 
of cost/benefit analysis. It is time 
to change; such analysis can be a 
valuable resource. □ 
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E THESE DATES... 
September 12-14, 1991-St. Louis, Missouri 
Scientific Program (CME) 
Oth Animal Wendell G. Scott Memorial Lecture 
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